Table 1.
Baseline patient demographic and clinical characteristics.
| Characteristic | Video Visit Cohort (n=134) |
In-Person Cohort (n=140) |
P-Value |
|---|---|---|---|
| Age, years | 42.8±8.9 | 45.0±12.1 | .10 |
| Male (%) | 97 (74) | 111 (79) | .26 |
| Systolic BP, mmHg | 123±13 | 128±21 | .014 |
| Diastolic BP, mmHg | 78±11 | 81±9 | .016 |
| Lipid panel | |||
| Total cholesterol, mg/dL | 196±43 | 184±49 | .053 |
| LDL-C, mg/dL | 130±39 | 114±43 | .003 |
| HDL-C, mg/dL | 50±14 | 50±19 | .88 |
| Triglycerides, mg/dL | 125±68 | 129±80 | .65 |
| Statin use (%) | 30 (22) | 54 (39) | .004 |
| HbA1c, % | 5.9±1.1 | 5.7±0.7 | .27 |
| Body mass index, kg/m2 | 26.3±4.6 | 26.8±3.8 | .36 |
| Smoking status (%) | |||
| Non-smoker | 101 (75) | 114 (81) | .99 |
| Former smoker | 19 (14) | 20 (14) | .86 |
| Current smoker | 3 (2.2) | 6 (4.3) | .50 |
Mean ± standard deviation is reported for continuous variables. Data were available for >90% of patients except for lipid panel and HbA1c. BP denotes blood pressure, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, HbA1c hemoglobin A1c.